Patriot Financial Group Insurance Agency, LLC Bristol Myers Squibb CO Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $685 Million
  • Q1 2025

A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 5,303 shares of BMY stock, worth $249,241. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,303
Previous 4,975 6.59%
Holding current value
$249,241
Previous $281,000 14.95%
% of portfolio
0.05%
Previous 0.04%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025
BUY
$53.9 - $63.11 $17,679 - $20,700
328 Added 6.59%
5,303 $323,000
Q4 2024

Jan 22, 2025
SELL
$51.92 - $59.94 $32,190 - $37,162
-620 Reduced 11.08%
4,975 $281,000
Q3 2024

Oct 24, 2024
BUY
$39.66 - $51.75 $8,169 - $10,660
206 Added 3.82%
5,595 $289,000
Q2 2024

Jul 26, 2024
BUY
$40.25 - $52.99 $17,991 - $23,686
447 Added 9.04%
5,389 $223,000
Q1 2024

Apr 30, 2024
BUY
$47.98 - $54.4 $25,429 - $28,832
530 Added 12.01%
4,942 $268,000
Q4 2023

Jan 19, 2024
SELL
$48.48 - $57.85 $16,677 - $19,900
-344 Reduced 7.23%
4,412 $226,000
Q3 2023

Oct 19, 2023
SELL
$57.89 - $64.73 $13,719 - $15,341
-237 Reduced 4.75%
4,756 $276,000
Q2 2023

Jul 17, 2023
SELL
$63.71 - $70.74 $8,664 - $9,620
-136 Reduced 2.65%
4,993 $319,000
Q1 2023

Apr 20, 2023
SELL
$65.71 - $74.53 $62,490 - $70,878
-951 Reduced 15.64%
5,129 $355,000
Q4 2022

Jan 17, 2023
BUY
$68.48 - $81.09 $57,249 - $67,791
836 Added 15.94%
6,080 $0
Q3 2022

Oct 31, 2022
BUY
$0.13 - $76.84 $25 - $15,137
197 Added 3.9%
5,244 $373,000
Q2 2022

Jul 29, 2022
SELL
$72.62 - $79.98 $23,165 - $25,513
-319 Reduced 5.94%
5,047 $389,000
Q1 2022

May 11, 2022
SELL
$61.48 - $73.72 $105,622 - $126,650
-1,718 Reduced 24.25%
5,366 $392,000
Q4 2021

Jan 10, 2022
SELL
$53.63 - $62.52 $793,241 - $924,733
-14,791 Reduced 67.62%
7,084 $442,000
Q3 2021

Nov 24, 2021
SELL
$59.17 - $69.31 $4,201 - $4,921
-71 Reduced 0.32%
21,875 $1.29 Million
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $40,055 - $43,620
647 Added 3.04%
21,946 $1.47 Million
Q1 2021

Apr 29, 2021
SELL
$59.34 - $66.74 $134,523 - $151,299
-2,267 Reduced 9.62%
21,299 $1.35 Million
Q4 2020

Jan 15, 2021
BUY
$57.74 - $65.43 $190,542 - $215,919
3,300 Added 16.28%
23,566 $1.46 Million
Q3 2020

Oct 21, 2020
SELL
$57.43 - $63.64 $19,985 - $22,146
-348 Reduced 1.69%
20,266 $1.22 Million
Q2 2020

Jul 10, 2020
BUY
$54.82 - $64.09 $740,947 - $866,240
13,516 Added 190.42%
20,614 $1.21 Million
Q1 2020

Apr 15, 2020
BUY
$46.4 - $67.43 $24,406 - $35,468
526 Added 8.0%
7,098 $396,000
Q4 2019

Jan 22, 2020
BUY
$49.21 - $64.19 $71,649 - $93,460
1,456 Added 28.46%
6,572 $422,000
Q3 2019

Oct 25, 2019
BUY
$42.77 - $50.71 $16,979 - $20,131
397 Added 8.41%
5,116 $259,000
Q2 2019

Aug 07, 2019
SELL
$44.62 - $49.34 $237,155 - $262,242
-5,315 Reduced 52.97%
4,719 $220,000
Q1 2019

Apr 29, 2019
BUY
$45.12 - $53.8 $47,601 - $56,759
1,055 Added 11.75%
10,034 $479,000
Q4 2018

Feb 04, 2019
BUY
$48.76 - $63.23 $33,400 - $43,312
685 Added 8.26%
8,979 $467,000
Q3 2018

Oct 30, 2018
BUY
$55.19 - $62.25 $290,851 - $328,057
5,270 Added 174.27%
8,294 $515,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $313,235 - $390,413
-6,199 Reduced 67.21%
3,024 $167,000
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $3,894 - $4,483
-65 Reduced 0.7%
9,223 $572,000
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $17,802 - $19,408
-297 Reduced 3.1%
9,288 $574,000
Q3 2017

Oct 26, 2017
BUY
$55.23 - $63.74 $45,122 - $52,075
817 Added 9.32%
9,585 $615,000
Q2 2017

Aug 08, 2017
BUY
N/A
8,768
8,768 $490,000

Others Institutions Holding BMY

# of Institutions
2,806
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.9B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email